Technical Analysis for MNKD - MannKind Corporation

Grade Last Price % Change Price Change
D 4.3 -5.70% -0.26
MNKD closed down 5.7 percent on Thursday, April 15, 2021, on 63 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up
Historical MNKD trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Stochastic Sell Signal Bearish 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Crossed Above 50 DMA Bullish -5.70%
Pocket Pivot Bullish Swing Setup -5.70%
Wide Bands Range Expansion -5.70%
Overbought Stochastic Strength -5.70%
Stochastic Sell Signal Bearish 2.14%
Older End-of-Day Signals for MNKD ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 17 hours ago
Fell Below 50 DMA about 17 hours ago
60 Minute Opening Range Breakdown about 19 hours ago
Down 3% about 19 hours ago
Down 2 % about 21 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate includes AFREZZA inhalation powder, an insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. The company also develops MedTone and Dreamboat inhaler devices. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Boat Organ Systems Diabetes Therapeutic Product Therapeutic Products Dosage Forms Endocrine System Insulin Inhaler Hyperglycemia Thousand Oaks

Is MNKD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.25
52 Week Low 1.14
Average Volume 6,651,549
200-Day Moving Average 2.87
50-Day Moving Average 4.41
20-Day Moving Average 3.92
10-Day Moving Average 4.24
Average True Range 0.31
ADX 19.66
+DI 28.53
-DI 15.24
Chandelier Exit (Long, 3 ATRs ) 3.72
Chandelier Exit (Short, 3 ATRs ) 4.06
Upper Bollinger Band 4.63
Lower Bollinger Band 3.22
Percent B (%b) 0.77
BandWidth 36.05
MACD Line 0.07
MACD Signal Line -0.01
MACD Histogram 0.08
Fundamentals Value
Market Cap 1 Billion
Num Shares 233 Million
EPS -0.35
Price-to-Earnings (P/E) Ratio -12.15
Price-to-Sales 10.60
Price-to-Book 0.00
PEG Ratio -0.23
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.90
Resistance 3 (R3) 4.95 4.81 4.80
Resistance 2 (R2) 4.81 4.65 4.78 4.77
Resistance 1 (R1) 4.55 4.56 4.48 4.50 4.73
Pivot Point 4.41 4.41 4.37 4.38 4.41
Support 1 (S1) 4.15 4.25 4.08 4.10 3.87
Support 2 (S2) 4.01 4.16 3.98 3.83
Support 3 (S3) 3.75 4.01 3.80
Support 4 (S4) 3.70